HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Russell A Norris Selected Research

Cardiac Sudden Death (Sudden Cardiac Arrest)

12/2022Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel.
1/2020The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Russell A Norris Research Topics

Disease

5Mitral Valve Insufficiency (Mitral Regurgitation)
12/2023 - 12/2022
3Fibrosis (Cirrhosis)
01/2023 - 03/2008
3Mitral Valve Prolapse
02/2022 - 09/2015
2Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2022 - 01/2020
2Loeys-Dietz Syndrome
01/2014 - 11/2012
2Hypertrophy
10/2010 - 03/2008
1Ischemia
05/2024
1Heart Injuries
05/2024
1Reperfusion Injury
10/2023
1Acute Coronary Syndrome
10/2023
1Tauopathies
01/2023
1Left Ventricular Dysfunction
12/2022
1Fibrosarcoma
11/2022
1Melanoma (Melanoma, Malignant)
11/2022
1Cardiomyopathies (Cardiomyopathy)
11/2022
1Cardiotoxicity
11/2022
1Pain (Aches)
11/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1COVID-19
01/2020
1Malaria
01/2020
1Rheumatoid Arthritis
01/2020
1Cysts
01/2019
1Congenital Heart Defects (Congenital Heart Defect)
03/2016
1Cicatrix (Scar)
02/2016
1Prolapse
12/2015
1Atrioventricular Septal Defect
09/2015
1Aneurysm (Aneurysms)
01/2014
1Heart Valve Diseases (Valvular Heart Disease)
01/2013
1Aortic Valve Disease
01/2013
1Marfan Syndrome (Marfan's Syndrome)
11/2012
1Aortic Aneurysm (Aneurysm, Aortic)
11/2012
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2010
1Atherosclerosis
02/2010
1Atrial Heart Septal Defects (Atrial Septal Defect)
04/2008
1Heart Failure
03/2008

Drug/Important Bio-Agent (IBA)

3GadoliniumIBA
10/2023 - 01/2023
3Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2008
3PeriostinIBA
10/2010 - 03/2008
2SeptinsIBA
02/2022 - 01/2020
2FilaminsIBA
01/2021 - 09/2015
2LigandsIBA
11/2020 - 01/2014
2CollagenIBA
01/2019 - 03/2008
1Connexin 43 (Connexin43)IBA
05/2024
1Peptides (Polypeptides)IBA
05/2024
1TubulinIBA
01/2023
1Amyloid beta-PeptidesIBA
01/2023
1trametinibIBA
11/2022
1MitogensIBA
11/2022
1Phosphotransferases (Kinase)IBA
11/2022
1Opioid Receptors (Opioid Receptor)IBA
11/2020
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2020
1VaccinesIBA
01/2020
1Therapeutic UsesIBA
01/2020
1GelsIBA
01/2019
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2019
1MEF2 Transcription FactorsIBA
03/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2015
1Messenger RNA (mRNA)IBA
09/2015
1MorpholinosIBA
09/2015
1Angiotensin IIIBA
01/2014
1Serotonin (5 Hydroxytryptamine)IBA
01/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2012
1Neutralizing AntibodiesIBA
10/2010
1Losartan (Cozaar)FDA LinkGeneric
10/2010
1Angiotensin II Type 1 Receptor BlockersIBA
10/2010
1IntegrinsIBA
02/2010

Therapy/Procedure

5Therapeutics
12/2023 - 02/2016
1Heart Transplantation (Grafting, Heart)
10/2023